SCHEMBL7462801

SCHEMBL7462801

CCS(=O)(=O)Nc1c(Cl)c(Cl)cc2nc(OC)c(OC)nc12

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CCR4 P51679 10/20 0.36
LY6K Q17RY6 1/20 0.34
BRAF P15056 1/20 0.34
HPGD P15428 2/20 0.34
LMNA P02545 1/20 0.34
HSD17B10 Q99714 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HIF1A Q16665 1/20 0.34
PIK3CD O00329 1/20 0.34
EGFR P00533 1/20 0.34
PIK3CA P42336 1/20 0.34
PIK3CB P42338 1/20 0.34
PIK3CG P48736 1/20 0.34
EGLN1 Q9GZT9 1/20 0.33
PGK1 P00558 1/20 0.33
GSK3B P49841 1/20 0.33
MAP4K2 Q12851 1/20 0.33
GLP1R P43220 1/20 0.32
SGK1 O00141 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7466587 0.86 CCR4 (0.36) CCR4HPGDHSD17B10SMN1; SMN2HIF1A
SCHEMBL7472870 0.81 SLC40A1 (0.45) CCR4LMNAHSD17B10SMN1; SMN2HIF1A
SCHEMBL7472004 0.80 ALDH1A1 (0.36) CCR4LY6KHPGDLMNAHSD17B10
SCHEMBL7465420 0.78 SMN1; SMN2 (0.33) CCR4BRAFLMNAHSD17B10SMN1; SMN2
SCHEMBL7470948 0.77 GLP1R (0.33) CCR4HPGDLMNAHSD17B10SMN1; SMN2
SCHEMBL7475650 0.76 CCR4 (0.35) CCR4HPGDHSD17B10PIK3CDPIK3CA
SCHEMBL7467654 0.76 NPY1R (0.37) CCR4HSD17B10SMN1; SMN2HIF1APIK3CD
SCHEMBL7680466 0.76 CYP1A2 (0.39) HPGDHSD17B10SMN1; SMN2PGK1
SCHEMBL8935311 0.75 SMN1; SMN2 (0.32) CCR4BRAFLMNASMN1; SMN2HIF1A
SCHEMBL7470559 0.75 HRH4 (0.32) PGK1GSK3BMAP4K2GLP1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0783495-B1 QUINOXALINE DERIVATIVES USEFUL IN THERAPY PFIZER LTD (GB) 2002-02-27 EP disclosed
US-5852016-A Quinoxaline derivatives useful in therapy PFIZER INC. (US) 1998-12-22 US disclosed
EP-0783495-A1 QUINOXALINE DERIVATIVES USEFUL IN THERAPY Pfizer Limited (GB) 1997-07-16 EP disclosed
WO-1996009295-A1 QUINOXALINE DERIVATIVES USEFUL IN THERAPY PFIZER LIMITED (GB) 1996-03-28 WO disclosed